Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease. - sprookjes - yvandenbroek - TriplyDB

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.

http://www.wikidata.org/entity/Q37591146

about

Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.

P2860

Q50055669-AC06DE4A-ADE2-44A3-95C3-AB2AAD29F98B

P2860

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.

http://www.wikidata.org/entity/Q37591146

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Combined LRRK2 mutation, aging ...... model of Parkinson's disease.

@en

Combined LRRK2 mutation, aging ...... model of Parkinson's disease.

@nl

type

label

Combined LRRK2 mutation, aging ...... model of Parkinson's disease.

@en

Combined LRRK2 mutation, aging ...... model of Parkinson's disease.

@nl

prefLabel

Combined LRRK2 mutation, aging ...... model of Parkinson's disease.

@en

Combined LRRK2 mutation, aging ...... model of Parkinson's disease.

@nl

P1433

Q37591146-A729FE4E-A496-46A2-AE36-66B4165AD97A

P1476

Q37591146-04DEC315-2431-45FB-BAA5-032F9D680BFC

P2093

Q37591146-20B0C593-CBB6-4143-8DAE-325E59D2FD9C

Q37591146-4C0A160E-DC15-4266-BB81-D0976A7942C5

Q37591146-88B19E34-C681-4670-83A3-C25A9999A885

Q37591146-8F34312B-2009-4A03-AE15-895A9BB6BF19

Q37591146-9F93A07C-CC7E-44F0-BBB4-2FC36905DAF0

Q37591146-A94D7FB3-49D2-4631-9C1C-FC2FBCC0AF6E

Q37591146-C387A9BC-3593-427A-B2C0-5459DCA1F555

Q37591146-CD955024-3693-46C0-9CF4-A15C26AF1DEA

Q37591146-CD9E9437-79BE-4BFE-B6FB-E75E221F5D16

P2860

Q37591146-00560F97-BEF3-4597-A86D-4091F1A4D850

Q37591146-033D717A-18B1-4478-91D4-479DAFCB569C

Q37591146-042BA2D8-1FF4-4286-A9CB-82CAE9E9A3DE

Q37591146-05D0793B-1EF1-4C36-B0F4-5775B8E96280

Q37591146-05E0DF18-443D-4A12-90B2-10356AA831D1

Q37591146-0DBA372D-00FA-445E-84E7-140A32EAD30F

Q37591146-0DE0266A-CDFB-4011-82AC-63C5368EAEBE

Q37591146-0FEBA8AE-B924-4538-B414-ACA31B2D5CC4

Q37591146-1125889E-9A4A-41C4-9778-37C0B894EFD4

Q37591146-14C941C0-CE8C-4A9C-A1DD-A6028289B49F

P2888

Q37591146-E7D79D8B-6252-46B3-8169-3B30BE1F43D4

P304

Q37591146-99CDB985-0AA0-48B5-BA07-5B0A4D7B5D91

P31

Q37591146-D22DF2C5-E631-452C-BF36-D463B7E26087

P356

Q37591146-EB4BA22F-624F-4DC4-8EEE-95C3A215DDD6

P407

Q37591146-F2DB6FF1-4A79-4803-9990-7A52716102EE

P478

Q37591146-1BCB496E-0C6D-4832-A7B0-BD5A6380065F

P577

Q37591146-7BA8BC35-F73C-4E84-9EB6-7BA660006E7A

P698

Q37591146-4EA929E8-F23E-4E96-BB1B-DA6D0289D244

P921

Q37591146-CB4D3ED5-7810-4FC9-9FBB-22C12202923B

P932

Q37591146-C0D2740F-50DA-4828-8335-37A43E7F73FC

P356

P1433

Scientific Reports

P1476

Combined LRRK2 mutation, aging ...... model of Parkinson's disease.

@en

P2093

Colin Siu-Chi Lam

http://www.w3.org/2001/XMLSchema#string

David Boyer Ramsden

http://www.w3.org/2001/XMLSchema#string

Gideon Chi-Ting Leung

http://www.w3.org/2001/XMLSchema#string

Hui-Fang Liu

http://www.w3.org/2001/XMLSchema#string

Lingfei Li

http://www.w3.org/2001/XMLSchema#string

Michelle Hiu-Wai Kung

http://www.w3.org/2001/XMLSchema#string

Philip Wing-Lok Ho

http://www.w3.org/2001/XMLSchema#string

Shirley Yin-Yu Pang

http://www.w3.org/2001/XMLSchema#string

Shu-Leong Ho

http://www.w3.org/2001/XMLSchema#string

P2860

Uncoupling protein-4 (UCP4) increases ATP supply by interacting with mitochondrial Complex II in neuroblastoma cells

Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.

Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice

Rotenone, paraquat, and Parkinson's disease

Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

Premature ageing in mice expressing defective mitochondrial DNA polymerase

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1

Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

The role of the LRRK2 gene in Parkinsonism

P2888

P304

40887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP40887

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28098219

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

5241661

http://www.w3.org/2001/XMLSchema#string